Pages that link to "Item:Q3079028"
From MaRDI portal
The following pages link to Seamlessly Expanding a Randomized Phase II Trial to Phase III (Q3079028):
Displaying 11 items.
- A review of phase 2-3 clinical trial designs (Q1029784) (← links)
- Bayesian statistics and the efficiency and ethics of clinical trials (Q1766323) (← links)
- Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694) (← links)
- SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION (Q5066789) (← links)
- A Parallel Phase I/II Clinical Trial Design for Combination Therapies (Q5459586) (← links)
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen (Q5901511) (← links)
- Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers (Q6055528) (← links)
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs (Q6618333) (← links)
- Multilevel joint frailty model for hierarchically clustered binary and survival data (Q6626897) (← links)
- Joint modeling of binary response and survival for clustered data in clinical trials (Q6627304) (← links)
- Design of phase III trials with long-term survival outcomes based on short-term binary results (Q6628430) (← links)
